Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2025
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has notified the stock exchanges about its 29th AGM scheduled for Friday, September 26, 2025, at 4:00 PM via video conferencing. Shareholders will consider adoption of audited standalone and consolidated financial statements for FY2024-25 and approve a dividend of Rs. 1 per equity share (10% on face value of Rs. 10), with the record date set as September 12, 2025. Several director re-appointments are on the agenda: Mr. Chintan Shah as Managing Director and Mr. Ajaykumar Patel and Mr. Shekhar Somani as Whole-time Directors, each for one year from February 2026, plus second five-year terms for three Independent Directors. The company also seeks shareholder approval to appoint M/s. TNT & Associates as Secretarial Auditors for five years (FY2025-26 to FY2029-30) and ratifies Rs. 80,000 remuneration for Cost Auditors. E-voting will be open from September 23 to September 25, 2025, and the register of members will be closed from September 13 to September 26, 2025.
Shareholders should note the September 12, 2025 record date to be eligible for the Rs. 1 dividend (subject to AGM approval). The agenda is largely routine — director re-appointments and auditor confirmations — with no major corporate actions like fundraising or M&A, so limited stock price impact is expected beyond standard AGM-related activity.